Skip to content

A Post-Marketing Study for On Label Evaluation of the GE Vscan Ultrasound Imaging System

A Post-Marketing Study for On Label Evaluation of the GE Vscan Ultrasound Imaging System

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01076296
Enrollment
1000
Registered
2010-02-26
Start date
2010-02-28
Completion date
2012-07-31
Last updated
2016-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Valve Diseases, Left Ventricular Dysfunction, Pulmonary Hypertension, Right Ventricular Dysfunction

Brief summary

This study is to collect data and learn more about the Vscan Ultrasound Imaging System. It is an observational study with no additional procedures or intervention prescribed other than using the Vscan along with a routine medical physical exam.

Detailed description

The study requires 2 visits to OHSU. At the first visit a cardiac physical exam will be done by a cardiologist. At a second visit, a different cardiologist will perform an ultrasound scan (as part of your standard of care) using a Vscan Ultrasound System. The first and the second visit may be done on the same day depending upon your schedule and if it's convenient for you to stay. The total exam time for both the visits, including standard exam and the study device exam will be about 45 minutes.

Interventions

None listed

Sponsors

Oregon Health and Science University
CollaboratorOTHER
GE Healthcare
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or older * provided signed and dated informed consent and is willing to provide GE Healthcare with demographic data, cardiac medical history, information collected as part of the study * New patients who have an echocardiogram less than 6 months and patients who will be undergoing an echocardiogram as part of their routine clinical care

Exclusion criteria

* Pregnant * less than 18 years of age. * unwilling to provide informed Consent

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Correct Diagnosis2 yearsA comparison of the percentages of correct diagnosis by VSCAN and clinical exam using a McNemar test for matched pairs with ECHO used as the gold standard.

Countries

United States

Participant flow

Participants by arm

ArmCount
Total for All Groups Assessed
Subjects assessed for LV function using both VScan and a clinical examination.
1,000
Total1,000

Baseline characteristics

CharacteristicTotal for All Groups Assessed
Age, Continuous60.9 years
STANDARD_DEVIATION 15.4
Sex: Female, Male
Female
656 Participants
Sex: Female, Male
Male
344 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
EG005
affected / at risk
EG006
affected / at risk
EG007
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —— / —— / —— / —— / —
other
Total, other adverse events
0 / 540 / 1960 / 510 / 1990 / 590 / 1910 / 510 / 199
serious
Total, serious adverse events
0 / 540 / 1960 / 510 / 1990 / 590 / 1910 / 510 / 199

Outcome results

Primary

Percentage of Correct Diagnosis

A comparison of the percentages of correct diagnosis by VSCAN and clinical exam using a McNemar test for matched pairs with ECHO used as the gold standard.

Time frame: 2 years

ArmMeasureValue (NUMBER)
Abnormal Left Ventricle FunctionPercentage of Correct Diagnosis61 percentage of correct diagnosis
Normal Left Ventricle FunctionPercentage of Correct Diagnosis31 percentage of correct diagnosis
Abnormal Right Ventricle FunctionPercentage of Correct Diagnosis47 percentage of correct diagnosis
Normal Right Ventricle FunctionPercentage of Correct Diagnosis6 percentage of correct diagnosis
Pulmonary HypertensionPercentage of Correct Diagnosis10 percentage of correct diagnosis
No Pulmonary HypertensionPercentage of Correct Diagnosis3 percentage of correct diagnosis
Heart Valve DiseasePercentage of Correct Diagnosis39 percentage of correct diagnosis
No Heart Valve DiseasePercentage of Correct Diagnosis4 percentage of correct diagnosis

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026